Get started
Author

Yashasvini Sampathkumar

Observed names: Sampathkumar, Yashasvini, Y. Sampathkumar
ORCID: 0009-0007-2120-2620
Observed ORCID: 0009-0007-2120-2620
OpenAlex ID: A5114474172
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer Measure
2025 · Yashasvini Sampathkumar, Corrine I. Voils, et al. · JCO Oncology Practice · 2
Drivers of Job Loss Among Chinese Breast Cancer Survivors: A Qualitative Analysis
2025 · Susan Chimonas, Yashasvini Sampathkumar, et al. · Psycho-Oncology · 2
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer
2026 · Yashasvini Sampathkumar, Ziad Zakaria, et al. · JNCI Journal of the National Cancer Institute · 1
Initial chemotherapy dose reductions and subsequent treatment delivery in stage I–IIIA breast cancer
2026 · Maria J. Monroy‐Iglesias, Kelli O’Connell, et al. · Cancer · 1
Evaluation of methods to identify chemotherapy‐related hematologic toxicities in real‐world settings
2025 · Peng Wang, Kelli O'Connell, et al. · International Journal of Cancer · 1
PDF
Assessing the Impact of Lymphedema Therapy Referral on Breast Cancer Survivors’ Lymphedema Knowledge: A Cross-Sectional Survey
2025 · Madelyn Klugman, Yashasvini Sampathkumar, et al. · BMC Women s Health · 1
Trends in exercise initiation and participation among employed breast cancer survivors undergoing curative treatment
2024 · Sonal Oza, Sujata Patil, et al. · Breast Cancer Research and Treatment · 1
Prescription Drug Use Among US Adults
2026 · Maria J. Monroy-Iglesias, Peng Wang, et al. · JAMA Network Open
Intraoperative and Perioperative Outcomes of Breast-Conserving Surgery After Neoadjuvant Systemic Therapy: A Retrospective Cohort Study
2026 · Yashasvini Sampathkumar, Rebecca Yu, et al. · Clinical Breast Cancer
Assessing the Impact of Lymphedema Therapy Referral on Breast Cancer Survivors’ Lymphedema Knowledge: A Cross-Sectional Survey
2026 · Patil, Sujata, Tringale, Kathryn R., et al. · UNC Libraries
A taxonomy of work-related outcomes in cancer survivors to advance systematic assessments in research and practice
2026 · Victoria S Blinder, Yashasvini Sampathkumar, et al. · JNCI Journal of the National Cancer Institute
Patterns of chemotherapy delivery following neuropathy in patients with stage I-IIIA breast cancer.
2026 · Maria Jose Monroy Iglesias, Gaia S. Pocobelli, et al. · Journal of Clinical Oncology
Format matters: Digital vs print delivery of a job retention intervention during breast cancer therapy.
2026 · Yashasvini Sampathkumar, Emily Kasuga, et al. · Journal of Clinical Oncology
Neighborhood disadvantage and correlation with differences in somatic mutations in a real-world breast cancer cohort.
2026 · Jacquelyn Dillon, Xuechun Bai, et al. · Journal of Clinical Oncology
Response to Yu, Wang, and Ge
2026 · Yashasvini Sampathkumar, Ziad Zakaria, et al. · JNCI Journal of the National Cancer Institute
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)
2026 · Allison M. Deal, Yashasvini Sampathkumar, et al. · JCO Oncology Practice
Work accommodations described by a racially and socioeconomically diverse sample of women undergoing treatment for breast cancer
2026 · Carolyn E Eberle, Yashasvini Sampathkumar, et al. · Work
PDF
Abstract PS1-02-03: Talking to Employers and Medical Staff about Work: An Intervention to Increase Access to Work Accommodations
2026 · Y. Sampathkumar, E. Kasuga, et al. · Clinical Cancer Research
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer
2025 · Yashasvini Sampathkumar, Ziad Zakaria, et al. · JCO Oncology Practice
Workplace/employer accommodations during cancer treatment (WE-ACT): A mobile health app to promote job retention.
2025 · Yashasvini Sampathkumar, Emily Kasuga, et al. · JCO Oncology Practice
Impact of initial chemotherapy dosing on subsequent dosing patterns and treatment completion in early-stage breast cancer.
2025 · Maria Jose Monroy Iglesias, Kelli O'Connell, et al. · Journal of Clinical Oncology
PDF
Obesity, chemotherapy dosing, and toxicity: Results from the Optimal Breast Cancer Chemotherapy Dosing study.
2025 · Elizabeth Kantor, Kelli O'Connell, et al. · Journal of Clinical Oncology
Self-reported adherence to cancer therapy: Development and validation of a cancer-specific DOSE-Nonadherence measure.
2025 · Yashasvini Sampathkumar, Corrine Ione Voils, et al. · Journal of Clinical Oncology
Femoral Bulge
2025 · Yashasvini Sampathkumar, Jalpa Patel, et al. · Springer eBooks
Works count: 26
Citation count: 8
H-index: 1
I10-index:
Year
Topic
Type